Author

Lauranne Derikx 1

1 Jeroen Bosch Hospital, Gastroenterology and Hepatology, 's Hertogenbosch, Netherlands

BOTH SINGLE AND MULTIPLE SWITCHING BETWEEN INFLIXIMAB BIOSIMILARS CAN BE SAFE AND EFFECTIVE IN IBD: REAL WORLD OUTCOMES FROM THE EDINBURGH IBD UNIT

Spyridon (Spyros) Siakavellas, Nikolas Plevris, Eleanor Watson, Julia Gauci, Laura Alexandra Lucaciu, Rachael Barrett, Ian D.R. Arnott, Colin Noble, Lynne Merchant, Lauranne Derikx, Gareth R Jones, Charlie Lees

COLORECTAL CANCER RISK IN A NATIONWIDE INFLAMMATORY BOWEL DISEASE COHORT WITH LOW GRADE DYSPLASIA

Lauranne Derikx, Sanne van Tilburg, Iris D. Nagtegaal, Loes Nissen, Frank Hoentjen

FACTORS INDEPENDENTLY ASSOCIATED WITH FATIGUE IN IBD: RESULTS FROM THE BASELINE DATASET OF THE PREDICCT STUDY

Lauranne Derikx

FACTORS INDEPENDENTLY ASSOCIATED WITH FATIGUE IN IBD: RESULTS FROM THE BASELINE DATASET OF THE PREDICCT STUDY

Lauranne Derikx, Spyridon (Spyros) Siakavellas, Lisa Derr, Linda Williams, Nikolas Plevris, Philip Jenkinson, Laura Lucaciu, Nathan Constantine-Cooke, Lauren Murdoch, Janet Kyle, Alexandra Johnstone, Kate Covil, Gareth Rhys-Jones, Charlie Lees

INTESTINAL EPSTEIN- BARR VIRUS IS ASSOCIATED WITH MUCOSAL LYMPHOPROLIFERATION AND SUBSEQUENT INTESTINAL SURGERY IN INFLAMMATORY BOWEL DISEASE PATIENTS

Loes Nissen, Iris D. Nagtegaal, Dirk De Jong, Lauranne Derikx, Mitchell Lynch, Han van Krieken, Frank Hoentjen

LARGE DIFFERENCES IN IBD CARE AND EDUCATION ACROSS EUROPE, FIRST RESULTS OF THE PAN-EUROPEAN VIPER SURVEY

Nicolas Benech, Brigida Barberio, Vera Lanska, Jan Král, Andreas Blesl, Catarina Frias Gomes, Aileen Eek, Tiago Capela, Eduard Brunet, Lauranne Derikx, Matthias Lessing, Anthea Pisani, Marcin Włodarczyk, Haluk Tarik Kani, Dmytro Oliinyk, Jonathan Segal, Vita Skuja, Anna Kagramanova, Phil Harvey, Hubert Zatorski, Philipp

LATENT CROHN’S DISEASE SUBGROUPS ARE IDENTIFIED BY FAECAL CALPROTECTIN PROFILES: A RETROSPECTIVE ANALYSIS OF THE LOTHIAN CROHN’S DISEASE INCEPTION COHORT

Nathan Constantine-Cooke, Karla Monterrubio-Gómez, Nikolas Plevris, Lauranne Derikx, Beatriz Gros, Gareth-Rhys Jones, Riccardo Marioni, Charlie W. Lees, Catalina Vallejos

LONG-TERM OUTCOMES FOLLOWING A SWITCH FROM ORIGINATOR ADALIMUMAB TO THE BIOSIMILAR SB5 (IMRALDI) IN IBD

Lauranne Derikx

LONG-TERM OUTCOMES FOLLOWING A SWITCH FROM ORIGINATOR ADALIMUMAB TO THE BIOSIMILAR SB5 (IMRALDI) IN IBD

Heather Dolby, Laura Lucaciu, Caitlin Rees, Mathew Lyons, Lauranne Derikx, Nikolas Plevris, Shanna Su, Claire O'Hare, Laura Kirkpatrick, Lynne Merchant, Ian D Arnott, Nathan Constantine-Cook, Spyridon (Spyros) Siakavellas, Colin Noble, Philip Jenkinson, Gareth R Jones, Charlie Lees

PATIENT PERCEPTIONS ABOUT CAUSES OF FLARE IN INFLAMMATORY BOWEL DISEASE (IBD): RESULTS FROM THE BASELINE DATASET OF THE PREDICCT STUDY

Spyridon (Spyros) Siakavellas, Lisa Derr, Lauranne Derikx, Linda Williams, Nathan Constantin-Cooke, Nikolas Plevris, Kate Covil, Philip Jenkinson, Laura Alexandra Lucaciu, Lauren Murdoch, Gareth R Jones, Charlie Lees, Janet Kyle, Alexandra Johnstone

Item 1 - 10 / 11
1
2